Clinical Consequences of Nonnarcotic Analgesic Use

Abstract

Get full access to this article

View all access options for this article.

References

Zarama

, Abraham

P.A.

. Drug induced renal disease. In: DiPiro

J.T.

, Talbert

R.L.

, Yee

G.C.

, Matzke

G.R.

, Wells

B.G.

, Posey

L.M.

eds. Pharmacotherapy. Stamford, CT: Appleton & Lange, 1996, vol 3: 1007–31.

Matzke

. Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal antiinflammatory agents. Am J Kidney Dis 1996; 28(suppl 1): S63–70.

Fries

. Toward an understanding of NSAID-related adverse events: the contribution of longitudinal data. Scand J Rheumatol 1996; 25(suppl 102): 3–8.

McGoldrick

M.D.

, Bailie

G.R.

. Nonnarcotic analgesics: prevalence and estimated economic impact of toxicities. Ann Pharmacother 1997; 31: 221–7.

Anandan

J.V.

, Matzke

G.R.

. Nephropathy as a hazard of analgesic abuse. Am J Hosp Pharm 1981; 38: 1536–9.

Buckalew

Jr , Schey

H.M.

,. Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence. Medicine 1986; 11: 291–303.

Buckalew

Jr . Habitual use of acetaminophen as a risk factor for chronic renal failure: a comparison with phenacetin. Am J Kidney Dis 1996; 28(suppl 1): S7–13.

US Food and Drug Administration. Human drugs: prescription and over-the-counter drug products containing phenacetin; withdrawal of approval of new drug application. Fed Reg 1983; 48: 15466–9.

Brunner

F.P.

, Selwood

N.H.

EDTA-ERA Registry Committee. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. Nephrol Dial Transplant 1994; 9: 1371–6.

10.

Disney

APS

. Australia and New Zealand Dialysis and Transplant Registry. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation from the Australia and New Zealand Dialysis and Transplant Registry. Am J Kidney Dis 1995; 25: 165–75.

11.

Sandler

D.P.

, Smith

J.C.

, Weinberg

C.R.

, Buckalew

Jr , Dennis

V.W.

, Blythe

W.B.

, Analgesic use and chronic renal disease. N Engl J Med 1989; 320: 1238–43.

12.

Pommer

, Bronder

, Greiser

, Helmert

, Jesdinsky

H.J.

, Klimpel

Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol 1989; 9: 403–12.

13.

Morlans

, Laporte

J-R

, Vidal

, Cabeza

, Stolley

P.D.

,. End-stage renal disease and non-narcotic analgesics: a case control study. Br J Clin Pharmacol 1990; 30: 717–23.

14.

Sandler

D.P.

, Burr

F.R.

, Weinber

C.R.

. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991; 115: 165–72.

15.

Perneger

T.V.

, Whelton

P.K.

, Klag

M.J.

. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 1994; 331: 1675–9.

16.

Henrich

W.L.

, Agodoa

L.E.

, Barret

, Bennett

W.M.

, Blantz

R.C.

, Buckalew

V.M.

Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis 1996; 27: 162–5.

17.

Blantz

R.C.

. Acetaminophen: acute and chronic effects on renal function. Am J Kidney Dis 1996; 28(suppl 1): S3–6.

18.

Barrett

B.J.

. Acetaminophen and adverse chronic renal outcomes: an appraisal of the epidemiologic evidence. Am J Kidney Dis 1996; 28(suppl 1): S14–9.

19.

D'Agati

. Does aspirin cause acute or chronic renal failure in experimental animals and in humans? Am J Kidney Dis 1996; 28(suppl 1): S24–9.

20.

Zambraski

E.J.

, Rofrano

T.A.

, Ciccone

C.D.

. Effects of aspirin treatment on kidney function in exercising man. Med Sci Sports Exerc 1982; 14: 419–23.

21.

Muther

R.S.

, Bennett

W.M.

. Effect of aspirin on glomerular filtration rate in normal humans. Ann Intern Med 1980; 92: 386–7.

22.

Plotz

P.H.

, Kimberly

R.P.

. Acute effects of aspirin and acetaminophen on renal function. Arch Intern Med 1981; 141: 343–8.

23.

Bennett

W.M.

, Henrich

W.L.

, Stoff

J.S.

. The renal effects of nonsteroidal antiinflammatory drugs: summary and recommendations. Am J Kidney Dis 1996; 28(suppl 1): S56–62.

24.

Segasothy

, Samad

S.A.

, Zulfigar

, Bennett

W.M.

. Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994; 24: 17–24.

25.

Nuyts

G.D.

, Van Vlem

, Thys

, De Leersnijder

, D'Haese

P.C.

, Elseviers

M.M.

, New occupational risk factors for chronic renal failure. Lancet 1995; 346: 7–11.

26.

Duggin

G.G.

. Combination analgesic-induced kidney disease: the Australian experience. Am J Kidney Dis 1996; 28(suppl 1): S39–47.

27.

Elseviers

M.M.

, DeBroe

M.E.

. Combination analgesic involvement in the pathogenesis of analgesic nephropathy: the European perspective. Am J Kidney Dis 1996; 28 (suppl 1): S48–55.

28.

Sabatini

. Pathophysiologic mechanisms in analgesic-induced papillary necrosis. Am J Kidney Dis 1996; 28(suppl 1): S34–8.

29.

Champion de Crespigny

, Hewitson

, Birchall

, Kincaid-Smith

Caffeine potentiates the nephrotoxicity of mefanamic acid on the rat renal papilla. Am J Nephrol 1990: 10: 311–5.

30.

Elseviers

M.M.

, Bosteels

, Cambier

, DePaepe

, Godon

J.P.

, Lins

Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure — results of the Belgian study. Nephrol Dial Transplant 1992; 7: 479–86.

31.

Elseviers

M.M.

, Waller

, Nenov

, Levora

, Matousovic

, Tanquerel

Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure. Kidney Int 1995; 48: 1316–23.

32.

Elseviers

M.M.

, DeBroe

M.E.

. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures. Nephrol Dial Transplant 1994; 9: 41–6.

33.

Noels

L.M.

, Elseviers

M.M.

, DeBroe

M.E.

. Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathies: a comparative study in France, Sweden and Belgium. Nephrol Dial Transplant 1995; 10: 167–74.

34.

Elseviers

M.M.

, DeBroe

M.E.

. A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int 1995; 48: 1912–9.